Latest Breaking News On - Douglase onsi - Page 7 : comparemela.com

Leap Therapeutics Reports Second Quarter 2022 Financial Results

/PRNewswire/ Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

United statesUnited kingdomNew zealandMatthew deyoungDouglase onsiAmerican society of clinical oncologyPrnewswire leap therapeutics incSecurities exchangeBeigene ltdLeap therapeutics incUniversity of alabama at birminghamCancer centerClinical oncologyChief executive officerBeigene announced initiationOngoing distinguish study

Leap Therapeutics Board of Directors Member Dr Monica Bertagnolli Appointed as the Director of the National Cancer Institute

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics today announced.

United kingdomUnited statesNew zealandMatthew deyoungWeill cornellDouglase onsiMonica bertagnolliNational cancer instituteAmerican society of clinical oncologyAlliance for clinical trials in oncologyWomen cancer centerBeigene ltdHarvard medical schoolAlliance for clinical trial in oncology foundationPrnewswire leap therapeutics incAlliance foundation trials

Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer

/PRNewswire/ Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and BeiGene,.

United statesNew zealandUnited kingdomSouth koreaRepublic of koreaMatthew deyoungDavid wiseZev wainbergDouglase onsiSamuel klempnerCynthia sirardRebecca arendLangone healthDrug administrationBeigene ltdUniversity of alabama at birmingham

Leap Therapeutics (LPTX) and BeiGene (BGNE) Initiate New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer

Leap Therapeutics (LPTX) and BeiGene (BGNE) Initiate New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandSouth koreaRepublic of koreaDouglase onsipresidentDavid wiseZev wainbergDouglase onsiSamuel klempnerCynthia sirardRebecca arendLangone healthDrug administrationBeigene ltdUniversity of alabama at birminghamSecurities exchange

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today.

United statesUnited kingdomNew zealandMatthew deyoungDavid wiseDouglase onsiOncologist at perlmutter cancer centerLangone healthAmerican society of clinical oncologyBeigene ltdPrnewswire leap therapeutics incSecurities exchangeLeap therapeutics incPerlmutter cancer centerClinical oncologyAnnual meeting